GNLX - Genelux Corp
2.8
-0.030 -1.071%
Share volume: 111,330
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.83
-0.03
-0.01%
Summary score
41%
Profitability
43%
Dept financing
24%
Liquidity
58%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-117.07%
Return on assets
-24.45%
Return on sales
-52619.34%
Return on invested capital
142.32%
Total debt ratio
31.7%
Debt ratio change over timeo
-0.75%
Current Ratio
4.07%
Quick Ratio
3.01%
Cash Position Ratio
1.97%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-25.68%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
24.45%
Debt ratio change over timeo
0%
Current Ratio
4.48%
Quick Ratio
0%
Cash Position Ratio
1.67%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-32.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
25.6%
Debt ratio change over time
0%
Current Ratio
4.2%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-126.04%
Return on assets
-117.15%
Return on sales
-43031.43%
Return on invested capital
42.27%
Total debt ratio
-75.44%
Debt ratio change over time
-0.75%
Current Ratio
1.8%
Quick Ratio
2.34%
Cash Position Ratio
1.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GNLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -117.07% | 13.23% | 9.84% | 26.17% |
| Return on assets | -24.45% | 4.59% | 3.2% | 1.81% |
| Return on sales | -52619.34% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 142.32% | 8.51% | 10.28% | 4.83% |
| Profitability | 25% | 64% | 50% | 56% |
| Total debt ratio | 31.7% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -0.75% | -16.59% | -73.52% | 21.11% |
| Dept financing | 8% | 22% | 16% | 50% |
| Current Ratio | 4.48% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 1.67% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 17% | 22% | 14% |
| Short-term ratios | GNLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -25.68% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 24.45% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 4.48% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 1.67% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 35% | 34% | 21% |